Member
Aeris Biosciences
Aeris Biosciences™ engineers porous biomaterials with micro- and nanoscale hierarchical architectures that actively organize biology, promoting regenerative cell integration while preventing bacterial colonization. Our Aer™ platform spans wound repair, bone regeneration, and localized therapeutic delivery.
Industries
biotechnology
Nr. of Employees
small (1-50)
Expertise Areas
- Wound care and wound management
- Digital health for wound assessment
- Clinical program design for wound outcomes
- Commercial partnership development
Key Technologies
- Digital health platforms
- Remote patient monitoring
- Telemedicine-enabled assessment
- Wound healing therapeutics
Investors
Ohio Third Frontier
$200,000 funded.
Announced on 2024-04-23.
Ohio Third Frontier
$200,000 funded.
Announced on 2024-04-23.